| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |